S100A7A在胃癌中的表达及对增殖转移的影响

doi:10.3969/j.issn.1006-5725.2024.10.003

Abstract

Abstract:

Objective The objective of this study is to examine the expression level of the S100A7A protein in both gastric cancer tissues and cells， as well as to evaluate its impact on the malignant phenotype of gastric cancer （GC） cells. Methods Immunohistochemical assay was used to detect the expression characteristics of S100A7A in 21 gastric cancer tissues and their corresponding paracancerous tissues， as well as to investigate its correlation with gastric cancer clinicopathological factors. Gastric cancer cells were genetically modified to overexpress S100A7A through plasmid transfection. Subsequently， the impact of S100A7A on the proliferation， migration， and invasion capacities of gastric cancer cells was assessed using cell proliferation assays （EdU assay and plate cloning assay） as well as cell migration and invasion assays （Transwell assay and scratch assay）. Results The expression of S100A7A protein was higher in GC tissues than in paracancerous tissues； Overexpression of S100A7A may increase gastric cancer cell proliferation， migration， and invasion. Conclusion S100A7A is a possible oncogene in GC and is predicted to serve as a new diagnostic and therapeutic target for the disease.

Key words: gastric cancer, S100A7A, proliferation, migration, invasion

CLC Number:

R735.2

Wushuang XIAO,Linjie HONG,Zhen YU,Ping YANG,Jieming ZHANG,Siyang PENG,Xiangyang WEI,Yidong CHEN,Side LIU,Jide. WANG. Expression of S100A7A in gastric cancer and its effect on proliferation and metastasis[J]. The Journal of Practical Medicine, 2024, 40(10): 1344-1350.

Figures/Tables 5

References 34

1	SUNG H， FERLAY J， SIEGEL R L， et al. Global Cancer Statistics 2020： GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries［J］. CA Cancer J Clin，2021，71（3）：209-249. doi:10.3322/caac.21660 doi: 10.3322/caac.21660
2	YANG L， YING X， LIU S， et al. Gastric cancer： Epidemiology， risk factors and prevention strategies［J］. Chin J Cancer Res，2020，32（6）：695-704. doi:10.21147/j.issn.1000-9604.2020.06.03 doi: 10.21147/j.issn.1000-9604.2020.06.03
3	GBD 2017 STOMACH CANCER COLLABORATORS. The global， regional， and national burden of stomach cancer in 195 countries， 1990-2017： a systematic analysis for the Global Burden of Disease study 2017［J］. Lancet Gastroenterol Hepatol，2020，5（1）：42-54.
4	QIU H， CAO S， XU R. Cancer incidence， mortality， and burden in China： a time-trend analysis and comparison with the United States and United Kingdom based on the global epidemiological data released in 2020［J］. Cancer Commun （Lond）， 2021，41（10）：1037-1048. doi:10.1002/cac2.12197 doi: 10.1002/cac2.12197
5	SITARZ R， SKIERUCHA M， MIELKO J， et al. Gastric cancer： epidemiology， prevention， classification， and treatment［J］. Cancer Manag Res， 2018，10：239-248. doi:10.2147/cmar.s149619 doi: 10.2147/cmar.s149619
6	DONATO R， CANNON B R， SORCI G， et al. Functions of S100 proteins［J］. Curr Mol Med， 2013，13（1）：24-57. doi:10.2174/15665240130104 doi: 10.2174/15665240130104
7	BRESNICK A R， WEBER D J， ZIMMER D B. S100 proteins in cancer［J］. Nat Rev Cancer， 2015，15（2）：96-109. doi:10.1038/nrc3893 doi: 10.1038/nrc3893
8	BÜCHAU A S， HASSAN M， KUKOVA G， et al. S100A15， an antimicrobial protein of the skin： regulation by E. coli through Toll-like receptor 4［J］. J Invest Dermatol， 2007，127（11）：2596-2604. doi:10.1038/sj.jid.5700946 doi: 10.1038/sj.jid.5700946
9	ZHANG L， BU Z， SHEN J， et al. A novel circular RNA （hsa_circ_0000370） increases cell viability and inhibits apoptosis of FLT3-ITD-positive acute myeloid leukemia cells by regulating miR-1299 and S100A7A［J］. Biomed Pharmacother， 2020，122：109619. doi:10.1016/j.biopha.2019.109619 doi: 10.1016/j.biopha.2019.109619
10	O'CONNOR A， MCNAMARA D， O'MORÁIN C A. Surveillance of gastric intestinal metaplasia for the prevention of gastric cancer［J］. Cochrane Database Syst Rev， 2013（9）：D9322.
11	PIMENTEL-NUNES P， LIBÂNIO D， MARCOS-PINTO R， et al. Management of epithelial precancerous conditions and lesions in the stomach （MAPS Ⅱ）： European Society of Gastrointestinal Endoscopy （ESGE）， European Helicobacter and Microbiota Study Group （EHMSG）， European Society of Pathology （ESP）， and Sociedade Portuguesa de Endoscopia Digestiva （SPED） guideline update 2019［J］. Endoscopy， 2019，51（4）：365-388. doi:10.1055/a-0859-1883 doi: 10.1055/a-0859-1883
12	LORDICK F， CARNEIRO F， CASCINU S， et al. Gastric cancer： ESMO Clinical Practice Guideline for diagnosis， treatment and follow-up［J］. Ann Oncol， 2022，33（10）：1005-1020. doi:10.1016/j.annonc.2022.07.004 doi: 10.1016/j.annonc.2022.07.004
13	NAKAMURA Y， KAWAZOE A， LORDICK F， et al. Biomarker-targeted therapies for advanced-stage gastric and gastro-oesophageal junction cancers： an emerging paradigm［J］. Nat Rev Clin Oncol， 2021，18（8）：473-487. doi:10.1038/s41571-021-00492-2 doi: 10.1038/s41571-021-00492-2
14	YAMAGUCHI K， BANG Y J， IWASA S， et al. Trastuzumab Deruxtecan in Anti-Human Epidermal Growth Factor Receptor 2 Treatment-Naive Patients With Human Epidermal Growth Factor Receptor 2-Low Gastric or Gastroesophageal Junction Adenocarcinoma： Exploratory Cohort Results in a Phase Ⅱ Trial［J］. J Clin Oncol， 2023，41（4）：816-825. doi:10.1200/jco.22.00575 doi: 10.1200/jco.22.00575
15	YANG W J， ZHAO H P， YU Y， et al. Updates on global epidemiology， risk and prognostic factors of gastric cancer［J］. World J Gastroenterol， 2023，29（16）：2452-2468. doi:10.3748/wjg.v29.i16.2452 doi: 10.3748/wjg.v29.i16.2452
16	THRIFT A P， El-Serag H B. Burden of Gastric Cancer［J］. Clin Gastroenterol Hepatol，2020，18（3）：534-542. doi:10.1016/j.cgh.2019.07.045 doi: 10.1016/j.cgh.2019.07.045
17	GONZALEZ L L， GARRIE K， TURNER M D. Role of S100 proteins in health and disease［J］. Biochim Biophys Acta Mol Cell Res， 2020，1867（6）：118677. doi:10.1016/j.bbamcr.2020.118677 doi: 10.1016/j.bbamcr.2020.118677
18	BRESNICK A R. S100 proteins as therapeutic targets［J］. Biophys Rev， 2018，10（6）：1617-1629. doi:10.1007/s12551-018-0471-y doi: 10.1007/s12551-018-0471-y
19	ALLGÖWER C， KRETZ A L， VON KARSTEDT S， et al. Friend or Foe： S100 Proteins in Cancer［J］. Cancers （Basel）， 2020，12（8）：2037. doi:10.3390/cancers12082037 doi: 10.3390/cancers12082037
20	LIN Z， DENG L， JI J， et al. S100A4 hypomethylation affects epithelial-mesenchymal transition partially induced by LMP2A in nasopharyngeal carcinoma［J］. Mol Carcinog， 2016，55（10）：1467-1476. doi:10.1002/mc.22389 doi: 10.1002/mc.22389
21	LIU J， GUO Y， FU S， et al. Hypomethylation-induced expression of S100A4 increases the invasiveness of laryngeal squamous cell carcinoma［J］. Oncol Rep， 2010，23（4）：1101-1107. doi:10.3892/or_00000738 doi: 10.3892/or_00000738
22	XIE R， LOOSE D S， SHIPLEY G L， et al. Hypomethylation-induced expression of S100A4 in endometrial carcinoma［J］. Mod Pathol， 2007，20（10）：1045-1054. doi:10.1038/modpathol.3800940 doi: 10.1038/modpathol.3800940
23	BATYCKA-BARAN A， HATTINGER E， ZWICKER S， et al. Leukocyte-derived koebnerisin （S100A15） and psoriasin （S100A7） are systemic mediators of inflammation in psoriasis［J］. J Dermatol Sci， 2015，79（3）：214-221. doi:10.1016/j.jdermsci.2015.05.007 doi: 10.1016/j.jdermsci.2015.05.007
24	KURPET K， CHWATKO G. S100 Proteins as Novel Therapeutic Targets in Psoriasis and Other Autoimmune Diseases［J］. Molecules， 2022，27（19）：6640. doi:10.3390/molecules27196640 doi: 10.3390/molecules27196640
25	JI Y Z， LIU S R. Koebner phenomenon leading to the formation of new psoriatic lesions： evidences and mechanisms［J］. Biosci Rep， 2019，39（12）：BSR20193266. doi:10.1042/bsr20193266 doi: 10.1042/bsr20193266
26	KO J H， SON M Y， ZHOU Q， et al. TREX2 Exonuclease Causes Spontaneous Mutations and Stress-Induced Replication Fork Defects in Cells Expressing RAD51（K133A）［J］. Cell Rep， 2020，33（12）：108543. doi:10.1016/j.celrep.2020.108543 doi: 10.1016/j.celrep.2020.108543
27	HU L， KIM T M， SON M Y， et al. Two replication fork maintenance pathways fuse inverted repeats to rearrange chromosomes［J］. Nature， 2013，501（7468）：569-572. doi:10.1038/nature12500 doi: 10.1038/nature12500
28	PARUCHURI V， PRASAD A， MCHUGH K， et al. S100A7-downregulation inhibits epidermal growth factor-induced signaling in breast cancer cells and blocks osteoclast formation［J］. PLoS One， 2008，3（3）：e1741. doi:10.1371/journal.pone.0001741 doi: 10.1371/journal.pone.0001741
29	SNEH A， DEOL Y S， GANJU A， et al. Differential role of psoriasin （S100A7） in estrogen receptor α positive and negative breast cancer cells occur through actin remodeling［J］. Breast Cancer Res Treat， 2013，138（3）：727-739. doi:10.1007/s10549-013-2491-4 doi: 10.1007/s10549-013-2491-4
30	TAKAHATA M， INOUE Y， TSUDA H， et al. SKI and MEL1 cooperate to inhibit transforming growth factor-beta signal in gastric cancer cells［J］. J Biol Chem， 2009，284（5）：3334-3344. doi:10.1074/jbc.m808989200 doi: 10.1074/jbc.m808989200
31	LI R， GU Z， ZHANG X， et al. RNF115 deletion inhibits autophagosome maturation and growth of gastric cancer［J］. Cell Death Dis， 2020，11（9）：810. doi:10.1038/s41419-020-03011-w doi: 10.1038/s41419-020-03011-w
32	ZHONG B， WANG K， XU H， et al. Silencing Formin-like 2 inhibits growth and metastasis of gastric cancer cells through suppressing internalization of integrins［J］. Cancer Cell Int， 2018，18：79. doi:10.1186/s12935-018-0576-1 doi: 10.1186/s12935-018-0576-1
33	KÄLLBERG E， VOGL T， LIBERG D， et al. S100A9 interaction with TLR4 promotes tumor growth［J］. PLoS One， 2012，7（3）：e34207. doi:10.1371/journal.pone.0034207 doi: 10.1371/journal.pone.0034207
34	DHAR A， MALLICK S， GHOSH P， et al. Simultaneous inhibition of key growth pathways in melanoma cells and tumor regression by a designed bidentate constrained helical peptide［J］. Biopolymers， 2014，102（4）：344-358. doi:10.1002/bip.22505 doi: 10.1002/bip.22505

[1]	Jing LIU,Chuntao LENG,Yan. WANG. Study on the angiogenic ability of exosomes derived from dental pulp stem cells modified by circRNA SIPA1L1 [J]. The Journal of Practical Medicine, 2024, 40(9): 1211-1217.
[2]	Xiaomei CHEN,Anqi WANG,Jizhen YANG,Miao YU. Prognosis and immune correlation analysis of m1A/m5C/m6A/m7G regulated genes in gastric cancer [J]. The Journal of Practical Medicine, 2024, 40(9): 1230-1237.
[3]	Wenxin LI,Minjun LU,Li LIN,Yueqin LIU,Xiaolan. ZHU. circRAF1 regulates the proliferation and apoptosis of human ovarian granulosa cells [J]. The Journal of Practical Medicine, 2024, 40(7): 910-917.
[4]	Jianliang YAN,Zeyu XIE,Rongrong JING,Ming. CUI. Research on establishing gastric cancer lymph node metastasis prediction model based on machine learning and routine laboratory indicators [J]. The Journal of Practical Medicine, 2024, 40(6): 844-849.
[5]	Shu CHEN,Jinglei ZHANG,Kang RONG,Nan ZHANG,Weiyi SUN. Research progress of exosomes in distant metastasis and drug resistance of gastric cancer [J]. The Journal of Practical Medicine, 2024, 40(6): 870-876.
[6]	Li′na GAO,Xiaohui LIU,Yufang ZHANG,Xiaoling LIU,Xiaochun HE,Jing GAO,Li ZHANG,Jun SUN,Xiujuan WANG,Yan. DONG. Expression of lncRNA SNHG8 in placenta accreta and its effect on trophoblast invasion and migration [J]. The Journal of Practical Medicine, 2024, 40(5): 646-652.
[7]	Li XU,Shanshan HU,Haiming. ZHAO. LncRNA GNAS⁃AS1 participates in the proliferation and migration of gastric cancer cells by regulating the miR⁃449a/Notch1 axis [J]. The Journal of Practical Medicine, 2024, 40(4): 483-489.
[8]	Runwei MA,Chunjie MU,Wenting GUI,Yao DENG,Minzhang ZHAO,Min LIU,Yi SONG. LncRNA SENCR targeted miR⁃206 regulates proliferation and apoptosis of human vascular smooth muscle cells of aortic dissection tissues [J]. The Journal of Practical Medicine, 2024, 40(3): 302-308.
[9]	Jian ZHAO,Songjie LIU,Guanchao ZHANG,Yuhou SHEN,Fengchen LI,Bing XU. Expression of CENPF and miR⁃1⁃3p in the serum of patients with advanced gastric cancer and their correlation with prognosis [J]. The Journal of Practical Medicine, 2024, 40(3): 365-370.
[10]	Bing′er WU,Qing LI,Kerong YANG,Jian ZHANG,Yi YU,Lei LEI,Bo. HU. Impact of spermidine on proliferation and apoptosis in diffuse large B⁃cell lymphoma cell lines [J]. The Journal of Practical Medicine, 2024, 40(22): 3130-3137.
[11]	Qing LUO,Jinjin HUANG,Tingting REN,Ruihua ZHOU,Donghua XU,Zhenhua WANG,Guoying WANG. The effect of umbilical cord stem cell exosomes on the proliferation of dermal papilla cells [J]. The Journal of Practical Medicine, 2024, 40(20): 2828-2834.
[12]	Jun XU,Xiaoli WANG,Jingyi NI,Didi. ZHANG. Clinical efficacy and safety of disitamab vedotin in the treatment of advanced gastric cancer [J]. The Journal of Practical Medicine, 2024, 40(20): 2913-2917.
[13]	Chunyan NIU,Xiaoping WANG,Xiangyang ZHAO,Jiankang HUANG,Yue CHEN,Yongqiang SHI,Yongqiang SONG,Hui WANG,Xinguo WU,Yongdan BU,Jijin LI,Tao TAO,Jinhua WU,Changlin XUE,Fuyu ZHANG,Jinming YANG,Chunrong HAN,Juan YUAN,Yinling WU,Hongbing XIONG,Peng XIAO. A multicenter population investigation on precancerous lesions of gastric cancer in Lishui District， Nanjing [J]. The Journal of Practical Medicine, 2024, 40(20): 2929-2934.
[14]	Min WANG,Dan MU,Dejun KONG,Li YANG,Lu YE,Dan HE. HPV16 E6 regulates miR-23a expression and promotes invasion and migration of cervical cancer cells [J]. The Journal of Practical Medicine, 2024, 40(2): 146-152.
[15]	Jianbo YANG,Jichun SHAO,Zhijun ZENG,Tao ZHAO,Xing. WANG. Effect of lncRNA MIF⁃AS1 on the malignant biological behavior of prostate cancer cells by regulating the miR⁃423⁃5p/PYCR1 axis [J]. The Journal of Practical Medicine, 2024, 40(18): 2544-2549.

Expression of S100A7A in gastric cancer and its effect on proliferation and metastasis

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 5

References 34

Related Articles 15

Recommended Articles

Metrics

Comments